Navigation Links
Bayer Establishes US Special Access Program for Leukine(R) While Replacing Current Liquid Formulation
Date:1/23/2008

- Leukine lyophilized formulation temporarily reserved for patients with

Acute Myelogenous Leukemia (AML) and those experiencing bone marrow

transplantation graft failure or engraftment delay - Bayer will replace current 500 mcg liquid formulation; aims to restore US

supplies of Leukine to current levels as quickly as possible

WAYNE, N.J., Jan. 23 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today, following consultation with the United States Food and Drug Administration (FDA), that it will withdraw the current liquid formulation of Leukine(R) marketed in the US. This decision was made in light of an upward trend in spontaneous reports of adverse reactions, including syncope (fainting), which are temporally correlated with the liquid Leukine 500 mcg vial which currently contains EDTA (edetate disodium).

While Bayer works to increase supplies of lyophilized Leukine and reformulate the liquid Leukine (to eliminate EDTA), Bayer will establish a special access program for the currently marketed lyophilized Leukine 250 mcg vial which does not contain EDTA. The upward trend in adverse event reporting rates is only associated with the Leukine liquid 500 mcg vial containing EDTA. Bayer has not observed an upward trend in reporting rates of these adverse events in the marketed Leukine 250 mcg lyophilized vial which does not contain EDTA. These adverse reactions are listed in the Leukine prescribing information.

The special access program is designed to prioritize the supply of the lyophilized Leukine for patients with Acute Myelogenous Leukemia (AML) and those who are experiencing bone marrow transplantation engraftment failure or delay. Leukine is the only myeloid growth factor approved to reduce the incidence of infections resulting in early death following induction chemotherapy in older adults with AML and to prolong survival of patients with bone marrow graft failure or engraftment delay, as co
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bayer Corporation Renames Its U.S. Foundation, Refocuses Charitable Giving Areas
2. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Local Elementary and Middle Schools
3. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Pittsburgh-Area Elementary and Middle Schools
4. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Northern New Jersey Elementary and Middle Schools
5. New Bayer, United Nations Partnership Brings International Environment and Art Competition to Kansas City Area Elementary and Middle Schools
6. AUDIO from Medialink and Bayer: Use Caution When Choosing Your Cold Medicine
7. Bayer CropScience, Mertec and M.S. Technologies to Co-Develop New Soybean Trait Products
8. Bayer HealthCare Pharmaceuticals and MedAssets Supply Chain Systems Sign a Three-Year Agreement for Magnevist(R) Magnetic Resonance Contrast Media
9. Bayer Awards Making Science Make Sense Grant to Girl Scouts
10. Bayer Plants Trees With Chartiers Valley Intermediate School Students, Provides Free Environmental Education Materials
11. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... might be a new salve to dominate medicine cabinets of ... salamander. Salamanders may not be the cuddliest of animals, but ... seriously damaged body parts. Now, a new report published in ... , identifies a small protein (called a "peptide") from ... unlocking the secret of this amazing wound healing trick in ...
(Date:9/2/2014)... clear that a mother,s eating habits prior to pregnancy, ... on her offspring and their propensity for developing weight ... behind this phenomenon were unclear. According to new research ... The FASEB Journal F , scientists using an animal ... and an offspring,s risk of future obesity. This link ...
(Date:9/2/2014)... September 02, 2014 Concorde Career ... chosen to receive the 2014 Excellence in Community ... Schools and Colleges (ACCSC). , Every year, the ... community members who make outstanding contributions in their ... evaluated for the scope and impact of the ...
(Date:9/2/2014)... research involving mice suggests that the key to more ... cabinet. In a report published in the ... macrophages from the lungs of old mice had different ... young mice, but these changes were reversed by ibuprofen. ... on immune function," said Joanne Turner, Ph.D., a researcher ...
(Date:9/2/2014)... Splashtop Inc. , the worldwide leader ... NTT DoCoMo to deliver Splashtop Business Lite for ... is included in NTT DoCoMo’s “Business Plus” program. , ... empower users to remote access their corporate computers from ... million users worldwide. Splashtop delivers the best in ...
Breaking Medicine News(10 mins):Health News:Salamander skin peptide promotes quick and effective wound healing in mice 2Health News:How genes link a mother's diet to the risk of obesity in her offspring 2Health News:Concorde Career College North Hollywood Awarded 2014 Excellence in Community Service Award 2Health News:Splashtop and NTT DoCoMo Partner to Deliver “Splashtop Business Lite” Secure Remote Access Solution to Business Customers 2
... CHICAGO, July 28 Underscoring the need for meaningful health ... is running an ad today emphasizing common ground on health reform to ... ad runs nationally today in the Chicago Tribune , New ... will run in various medical trade publications. , ...
... , , NEW ORLEANS, ... with eye and vision problems across the United States, Louisiana ... assessments for infants between six to 12 months of age ... Charity(TM) - The AOA Foundation in partnership with The Vision ...
... MADISON, Wis., July 28 In today,s health environment, harmful ... risk to young children. And, at the same time, the FDA ... children under the age of four. Parents of young children are ... and healthy. Many are embracing preventative measures to improve their child,s ...
... , , , ... York State Department of Transportation announced that today, July 28, 2009, ... will be unhealthy, especially for sensitive individuals, such as children, seniors ... high levels of ground-level ozone pollution. The alert is issued for ...
... YORK, July 28 The National Center on Addiction and Substance Abuse ... elected to its board of directors. , , (Logo: ... Tuggle is senior vice president of Global Public Affairs and Communications at ... held a variety of positions in the U.S. and abroad where he ...
... , , , ... (OTC Bulletin Board: TCSR), which develops, manages and owns faith-based senior ... Deutsche Bank Berkshire Mortgage, Inc. for the development of a new ... Heights , an 82-unit, $10 million senior ...
Cached Medicine News:Health News:New AMA Ad Emphasizes Common Ground on Health Reform, Shares Vision to Fix Broken System 2Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 2Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 3Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 4Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 5Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 6Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 7Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 8Health News:HOWARU(R) Protect Clinically Shown to Reduce the Incidence and Severity of Cold and Flu Symptoms in Children 2Health News:Air Quality Action Day Declared for Today, July 28, 2009 2Health News:Clyde C. Tuggle, Senior Vice President at The Coca-Cola Company, Elected to CASA* Board 2Health News:Clyde C. Tuggle, Senior Vice President at The Coca-Cola Company, Elected to CASA* Board 3Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 2Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 3Health News:TrinityCare Senior Living Announces Funding Agreement for Fifth Senior Living Facility 4
(Date:9/2/2014)... Sept. 2, 2014  Abaxis, Inc. (NasdaqGS: ... instrumentation and consumables to the medical, research and veterinary ... and Chief Executive Officer, will present at the Morgan ... at 10:20 a.m. ET. The conference will be held ... New York City . About Abaxis ...
(Date:9/2/2014)...  Hologic, Inc. (NASDAQ: HOLX ) today announced ... will present at the Morgan Stanley Global Healthcare Conference in ... York on Tuesday, September 9, 2014 at 12:20 ... listen to the live audio webcast of the presentation on ... An archive of the presentation will be available for replay ...
(Date:9/2/2014)... SAN DIEGO , Sept. 2, 2014  Arena ... that the US Food and Drug Administration (FDA) has ... of pulmonary arterial hypertension. "The FDA ... clinical data submissions from sponsors to identify and designate ... help advance the evaluation and development of such products," ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference 2Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 2Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 3Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension 4
... ARLINGTON HEIGHTS, Ill., Sept. 12 Even as,many ... available today,we are stopped by our rear reflection and ... study published in the October issue of Plastic and,Reconstructive ... Plastic Surgeons (ASPS), reveals a new back lift procedure ...
... Ala., Sept. 11 - Southern,Research Institute and ... from a study testing Naltrexone-derived,pyridomorphinan (SoRI-9409) will ... of,the journal Biological Psychiatry. The publication is ... suggests that a new compound that,causes selective ...
Cached Medicine Technology:Say 'Goodbye' to Back Fat Rolls 2Novel Compound Shows Promise for Treatment of Alcoholism 2Novel Compound Shows Promise for Treatment of Alcoholism 3Novel Compound Shows Promise for Treatment of Alcoholism 4
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
The Ultra HDL (UHDL) assay is used for the quantitation of high density lipoprotein (HDL) cholesterol in human serum or plasma....
... A histological embedment block ... This file system incorporates ... embedment block protection, simplified ... error and facilitation of ...
... The first instrumentation ... efficiently manage the ... Proven technology automatically ... collates cassettes sequentially. ...
Medicine Products: